FDA 510(k)

Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack

N.º K: K173798 · 2018-03-14

Fecha de decisión2018-03-14

Código de productoPGI

Comité asesorMI

DecisiónSubstantially Equivalent

Resumen del dispositivo

Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack is the device name listed in this FDA 510(k) record. The listed applicant is Diasorin Molecular, LLC. It received FDA 510(k) clearance on 2018-03-14 under 510(k) number K173798. The device is classified under product code PGI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack?

Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack is a medical device that received FDA 510(k) clearance on 2018-03-14. The listed applicant is Diasorin Molecular, LLC. The 510(k) number is K173798.

When did Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack receive FDA 510(k) clearance?

Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack received FDA 510(k) clearance on 2018-03-14, under 510(k) number K173798.

Who is the listed applicant for Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack?

The FDA 510(k) record lists Diasorin Molecular, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack?

The FDA product code for Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack is PGI.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Diasorin Molecular, LLC como solicitante

K260333LIAISON NES Group A Strep; LIAISON NES Group A Strep Control Swab Kit K251978LIAISON NES FLU A/B, RSV & COVID-19 K252387Simplexa™ COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa™ COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460)K220963Simplexa COVID-19 & Flu A/B Direct K202755Simplexa Congenital CMV Direct and Simplexa Congenital CMV Positive Control Pack K212147Simplexa COVID-19 Direct

Ver todos los 13 dispositivos →

Dispositivos relacionados (Código: PGI)

K233349Alinity m HSV 1 & 2 / VZVAbbott Molecular, Inc.K232286Savanna HSV 1+2/VZV Assay, Savanna HSV 1+2/VZV Control Set, Savanna InstrumentQuidel Corporation K192376Simplexa VZV Swab Direct, Simplexa VZV Positive Control PackDiasorin Molecular, LLC K180559HSV 1 & 2 ELITe MGB Kit; ELITe InGeniusElitechgroup K162451Solana HSV 1+2/VZV AssayQuidel Corporation

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.